CBD advertising in France: what the law forbids you to say

Each law has a different target: the packaging, the health promise, consumer information, the product's image. A single message can fall under several of them, and the penalties then add up.

A CBD flower sold for smoking falls into the category of "herbal products for smoking other than tobacco". Their labelling is governed by article L3514-3 of the Public Health Code. It bans any element suggesting that the product is less harmful than another, or that it has "vitalising, energising, curative, rejuvenating, natural, organic" properties or benefits for health or lifestyle.

Three details of this article often escape sellers. The words "natural" and "organic" are targeted just like a promise of a cure. The packaging also cannot claim a product is "additive-free" or make it look like a food or a cosmetic. And the ban covers "messages, symbols, names, product or service brands, figurative signs": a brand name that suggests healing falls under the text, just as a sentence would.

The penalty does exist. Article L3515-3 punishes with a €100,000 fine the use, on this packaging, of a message, brand or sign banned by article L3514-3, and with €200,000 for a repeat offence. The same article punishes selling a product whose packaging lacks the health warning. An order of 19 May 2016 sets its wording, "Fumer ce produit nuit à votre santé." ("Smoking this product harms your health."), over 30% of the front and 30% of the back.

These rules cover packaging. A product page, a shop window or a social media post falls under the other three laws. Our article on mandatory label information details what must appear.

The Public Health Code defines a medicine by what is said about it as much as by what it contains. Under article L5111-1, a medicine is "any substance or composition presented as having curative or preventive properties with regard to human diseases".

The trigger is therefore the seller's wording. Writing that an oil works against insomnia, anxiety or arthritis is enough to present it as a medicine, one lacking the authorisation that status requires. The only CBD medicine authorised in France is Epidyolex, prescribed for rare forms of epilepsy.

For products that are swallowed, the question is now settled upstream. France's agriculture ministry restated on 20 May 2026 that foods containing CBD are not authorised, supplements included. Our overview of CBD regulation in 2026 traces this change. For creams and balms, the cosmetics regulation sets its own limits, covered in our article on authorised cosmetic claims.

The Consumer Code bans misleading commercial practices. Article L121-2 lists them: a false or misleading claim about the product's composition, origin, conditions of use, "its properties and the results expected from its use", and about "the results and main features of tests and checks carried out".

That last point applies directly to CBD shops. Stating that a product is "tested batch by batch", or showing a level that does not match the batch sold, commits the seller just as a health promise does. Any mention of lab testing must be backed by a document you can show.

The penalties are set out in article L132-2: two years in prison and a €300,000 fine. The fine can rise to 10% of average annual turnover, or to 50% of the advertising spend. When the offence is committed through an online public communication service, the penalties rise to five years and €750,000. An online shop falls into that case.

Article L3421-4 of the Public Health Code punishes with five years in prison and a €75,000 fine any incitement to drug use, even without effect, and any presentation of drug use in a favourable light. The same penalty applies to inciting the use of substances "presented as having the effects" of narcotics. Near a school, the penalties rise to seven years and €100,000.

A report by France's addiction monitoring centres, funded by MILDECA, the government drug policy agency, and published on 1 December 2023, applies this law to CBD marketing. Its authors consider that terms borrowed from recreational cannabis, such as "space cake", "grinder" or "joint holder", amount to inciting drug use and may be prosecuted. A product sold as "as strong as THC" may fall under the second sentence of the article.

The same report reviewed 33 of the best-ranked online shops. Only a third stated that CBD is not a medicine, and one in two restricted use to adults. Some claims mentioned cardiovascular disease, psoriasis, seizures, cancer, multiple sclerosis or Parkinson's disease.

Vaping is the one clear case. Article L3513-5 bans selling or giving a vaping product to anyone under 18, with or without nicotine: a CBD e-liquid is covered.

For smokable flowers, the French Senate adopted in May 2026 a government amendment that extended this ban to herbal smoking products. As of 22 September 2026, the chapter of the code on these products still contains no ban on sales to minors. Refusing to sell to under-18s therefore remains the shop's own choice. Our article on the legal age for CBD goes through each format.

The safest approach is to describe what can be measured. The table lists common wording, the law it breaches and a factual alternative.

For a site's other obligations, our list of information a CBD shop must display completes this checklist, and our article on opening a CBD shop covers the steps.